The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML.
Leukemia
Charlet, Anne A; Kappenstein, Max M; Keye, Philip P; Kläsener, Kathrin K; Endres, Cornelia C; Poggio, Teresa T; Gorantla, Sivahari P SP; Kreutmair, Stefanie S; Sänger, Jana J; Illert, Anna L AL; Miething, Cornelius C; Reth, Michael M; Duyster, Justus J; Rummelt, Christoph C; von Bubnoff, Nikolas N
Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report.
Frontiers In Oncology
Ma, Chunhua C; Wang, Shuyuan S; Mu, Ning N; Li, Jinduo J; Liu, Mei M; Li, Lin L; Jiang, Rong R
High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage.
Therapeutic Advances In Medical Oncology
Borowczyk, Martyna M; Szczepanek-Parulska, Ewelina E; Dębicki, Szymon S; Budny, Bartłomiej B; Janicka-Jedyńska, Małgorzata M; Gil, Lidia L; Verburg, Frederik A FA; Filipowicz, Dorota D; Wrotkowska, Elżbieta E; Majchrzycka, Blanka B; Marszałek, Andrzej A; Ziemnicka, Katarzyna K; Ruchała, Marek M
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.
Leukemia
Reiter, K K; Polzer, H H; Krupka, C C; Maiser, A A; Vick, B B; Rothenberg-Thurley, M M; Metzeler, K H KH; Dörfel, D D; Salih, H R HR; Jung, G G; Nößner, E E; Jeremias, I I; Hiddemann, W W; Leonhardt, H H; Spiekermann, K K; Subklewe, M M; Greif, P A PA